Enterotrack commercializing device for non-invasive inflammation monitoring
EnteroTrack, LLC and the University of Colorado (CU) have executed an exclusive license agreement that will allow the company to develop and market a novel device to monitor inflammation of the gastrointestinal tract.
Jan 6, 2015
0
6